Activist Attack Puts Focus on Procter & Gamble Cost Cutting -- Update
18 July 2017 - 4:17AM
Dow Jones News
By Sharon Terlep
Over the years when Procter & Gamble Co. wasn't able to sell
more Tide or Pampers, the company could at least point to one clear
success: a sweeping, $10 billion cost-cutting plan executed ahead
of schedule.
Now that victory is murky.
Activist investor Nelson Peltz on Monday said he would seek a
single board seat in a shareholder vote at the company's annual
meeting, making P&G the largest company to ever face a proxy
fight.
Mr. Peltz's Trian Management Fund argues that P&G failed to
capitalize on a five-year savings plan that shrank the company by
tens of thousands of employees, more than a dozen factories and
hundreds of brands. Trian casts doubt on whether a second,
five-year, $10-billion savings plan announced by P&G last year
will produce results.
On Monday, P&G began mounting its defense, first pointing to
a series of metrics outlining the company's improved profit margin,
leaner structure and healthy cash generation.
"Over the past two years, P&G has accomplished the most
significant portfolio transformation in its history," the company
said. "Today, P&G is a leaner, more agile, more accountable and
more efficient organization."
The company also criticized Trian, arguing the hedge fund "has
not provided any new or actionable ideas to drive additional value
for P&G shareholders beyond the continued successful execution
of the strategic plan that is in place."
Trian, in meetings with P&G CEO David Taylor and other
managers, offered no specific suggestions on how the company could
better optimize cost savings, and was generally complimentary,
according to people familiar with the situation. P&G ultimately
saw no value in adding Mr. Peltz to the board, they said.
The activist isn't saying explicitly it wants more costs cut
than the $10 billion P&G has targeted, and isn't giving
specifics on how it would tackle the costs. But Trian is concerned
about whether the goal will be hit.
Trian says years of P&G's underperformance in revenue and
the stock market have raised questions about why the board should
be given another year to execute without Mr. Peltz in the
boardroom.
Central to Trian's case is the fate of roughly $3 billion of the
$10 billion in P&G's previous cost reductions. P&G said the
other $7 billion in savings were lost to currency fluctuations,
which Trian doesn't dispute.
Trian argues, however, that if P&G were operating
efficiently, the $3 billion would have shown up in increased sales
and profit growth, both of which have been stalled for years.
Trian is concerned the latest cost-cutting initiative "could be
as ineffective as the 2012 productivity program in driving sales
growth, earnings growth and shareholder creation," Trian said in a
regulatory filing Monday.
P&G shares were little changed Monday, rising less than 1%
to $87.67 in afternoon trading. The stock has gained 2% in the last
12 months, compared with a 14% return in the S&P 500.
Gary Bradshaw, a fund manager at Hodges Fund, said he would
support Mr. Peltz for the board. "I don't know he can change things
overnight but, now, earnings aren't growing and that's what will
eventually push the stock higher," said Mr. Bradshaw, whose fund
has about 150,000 P&G shares.
--David Benoit contributed to this article.
Write to Sharon Terlep at sharon.terlep@wsj.com
(END) Dow Jones Newswires
July 17, 2017 14:02 ET (18:02 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
Procter and Gamble (NYSE:PG)
Historical Stock Chart
From Apr 2024 to May 2024
Procter and Gamble (NYSE:PG)
Historical Stock Chart
From May 2023 to May 2024